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Computerised cognitive behaviour therapy (cCBT) as
treatment for depression in primary care (REEACT
trial): large scale pragmatic randomised controlled trial
The original trial registration for this Research paper (BMJ
2015;351:h5627, doi:10.1136/bmj.h5627), the REEACT trial
(http://www.controlled-trials.com/ISRCTN91947481), included
depression as a primary outcome, measured in two ways:
“Depression severity and symptomatology as measured by a
validated self-report measure (the Patient Health Questionnaire
[PHQ-9]) and the International Classification of Diseases
(ICD-10) depression score at fourmonths.” The original protocol
defined the primary outcome measure as “depression severity
and symptomatology as measured by the PHQ-9 and a
self-report computer-administered diagnostic interview (CIS-R)
at four months.” Before the start of the trial, the primary
outcome measure was modified to consist of only the PHQ-9
at four months. We did not collect ICD diagnosed depression
using a standardised interview schedule. The public document
detailing all revisions can be accessed in the full report at http:
//www.journalslibrary.nihr.ac.uk/hta/volume-19/issue-101#
chapters/2. One of our outcomes was a measure of quality
adjusted life years, which is published in the full economic
evaluation at http://www.journalslibrary.nihr.ac.uk/hta/volume-
19/issue-101#chapters/4.
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